A detailed history of Global Financial Private Client, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 411 shares of ZTS stock, worth $72,627. This represents 0.03% of its overall portfolio holdings.

Number of Shares
411
Previous 411 -0.0%
Holding current value
$72,627
Previous $71.3 Million 12.7%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

May 15, 2024

SELL
$160.94 - $186.23 $5,471 - $6,331
-34 Reduced 7.64%
411 $70 Million
Q1 2023

May 15, 2024

BUY
$145.48 - $175.02 $4,946 - $5,950
34 Added 8.27%
445 $74.6 Million
Q4 2021

May 15, 2024

BUY
$193.69 - $247.03 $77,863 - $99,306
402 Added 4466.67%
411 $100 Million
Q4 2020

May 15, 2024

SELL
$157.07 - $174.35 $41,623 - $46,202
-265 Reduced 96.72%
9 $1.49 Million
Q4 2019

May 15, 2024

BUY
$116.25 - $133.25 $31,852 - $36,510
274 New
274 $36.3 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Global Financial Private Client, LLC Portfolio

Follow Global Financial Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Financial Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Financial Private Client, LLC with notifications on news.